Promoter DNA methylation analysis reveals a combined diagnosis of CpG-based biomarker for prostate cancer

BACKGROUND: Prostate cancer (PCa) is the most common tumor in elderly men. However, the specificity and sensitivity of serum prostate-specific antigen levels in PCa diagnosis are controversial. This study aims to reveal a novel diagnosis biomarker in PCa. MATERIALS AND METHODS: The differential meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yuanyuan, Jiang, Shusuan, Gu, Yinmin, Li, Weidong, Mo, Zengnan, Huang, Yuanjie, Li, Tianyu, Hu, Yanling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601644/
https://www.ncbi.nlm.nih.gov/pubmed/28938548
http://dx.doi.org/10.18632/oncotarget.16437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601644/
https://www.ncbi.nlm.nih.gov/pubmed/28938548
http://dx.doi.org/10.18632/oncotarget.16437

Ejemplares similares